CIHH treatment corresponded with decreased macrophage infiltration; however, this did not reach statistical significance ( Figure 3A ).
← all excerpts
Chronic intermittent hypobaric hypoxia attenuates monocrotaline-induced pulmonary arterial hypertension via modulating inflammation and suppressing NF-κB/p38 pathway.
1
—
—